Duane E Rudisill

Title: Duane E Rudisill: Innovator in Chemokine Receptor Antagonism

Introduction

Duane E Rudisill is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmacology, particularly in the development of chemokine receptor antagonists. His work has implications for various therapeutic applications.

Latest Patents

Duane E Rudisill holds a patent for "Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof." This patent details crystalline forms of a C-C chemokine receptor type 4 (CCR4) antagonist, along with oral dosage forms and methods for using and preparing these compounds. This innovation is crucial for advancing treatment options in related medical fields. He has 1 patent to his name.

Career Highlights

Rudisill is currently associated with Rapt Therapeutics, Inc., where he continues to work on innovative solutions in drug development. His expertise in chemokine receptors has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout his career, Duane has collaborated with notable colleagues, including David J Arnold and Omar Robles. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Duane E Rudisill's contributions to the field of chemokine receptor antagonism exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in therapeutic applications.